ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Bill Would Empower FDA On Drug Safety

by David J. Hanson
August 9, 2010 | APPEARED IN VOLUME 88, ISSUE 32

A bill introduced by Sen. Michael F. Bennet (D-Colo.) would give new authority to FDA to ensure drug quality. Among other provisions, the Drug Safety & Accountability Act of 2010 gives FDA additional recall powers, allows the agency to require companies to increase oversight of overseas suppliers, and gives it new authority to assess penalties. The bill has the support of the Bulk Pharmaceuticals Task Force, an affiliate of the Society of Chemical Manufacturers & Affiliates. “About 80% of active drug ingredients come from overseas, yet they receive less than 5% of FDA’s resources,” said the task force’s chairman, Brant Zell, vice president of Cherokee Pharmaceuticals, in a statement. “This bill is a good starting point in giving FDA the resources to help ensure a safer U.S. drug supply.”

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment